patient
|
8 |
Age
|
63 |
Gender
|
female |
Origin
|
Germany |
Genotype
|
A |
PC_CP mutation
|
wt |
Weight(kg)
|
67 |
Duration of Pretreatment with Lamivudine (mo)
|
24 |
HBeAg Status at Baseline ADV
|
positive |
HBV DNA at Baseline ADV (log10 copies/mL)
|
8 |
Duration of ADV Therapy (mo)
|
19 |
HBV DNA at Baseline TDF (log10 copies/mL)
|
7.25 |